CSIMarket
 


Chiasma Inc   (CHMA)
Other Ticker:  
 
 

CHMA's Net Income Growth by Quarter and Year

Chiasma Inc 's Net Income results by quarter and year




CHMA Net Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - -19.81 -12.05 -8.08
III Quarter September - -18.46 -7.68 -7.47
II Quarter June - -21.13 -7.84 -8.67
I Quarter March -30.55 -15.39 -8.75 -7.04
FY   -30.55 -74.79 -36.32 -31.26



CHMA Net Income first quarter 2021 Y/Y Growth Comment
Chiasma Inc in the first quarter 2021 recorded net loss of $ -30.55 millions.

According to the results reported in the first quarter 2021, Chiasma Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Chiasma Inc ' s Net Income no change of % ranks overall at the positon no. in the first quarter 2021.




CHMA Net Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Chiasma Inc 's first quarter 2021 Net Income $ -30.55 millions CHMA's Income Statement
Chiasma Inc 's first quarter 2020 Net Income $ -15.39 millions Quarterly CHMA's Income Statement
New: More CHMA's historic Net Income Growth >>


CHMA Net Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Chiasma Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CHMA's I. Quarter Q/Q Net Income Comment
Recent results of -30.55 millions by Chiasma Inc look even worse considering the net loss -19.81 millions a quarter before.

Within Major Pharmaceutical Preparations industry Chiasma Inc achieved highest sequential Net Income growth. While Chiasma Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CHMA's I. Quarter Q/Q Net Income Comment
I. Quarter 2021 net loss of -30.55 millions by Chiasma Inc look even more unfavourable if you take a look at -19.81 millions in the fourth quarter.

Within Major Pharmaceutical Preparations industry Chiasma Inc achieved highest sequential Net Income growth. While Chiasma Inc 's Net Income growth quarter on quarter, overall rank is .


Chiasma Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Net Income 12 Months Ending $ -89.94 $ -74.78 $ -67.02 $ -56.24 $ -42.96
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Chiasma Inc ' has realized cumulative trailing twelve months net loss of $ -90 millions in the Mar 31 2021 period.
The situation is detiriorating as the cumulative net loss is getting bigger from $ -74.78 millions in the twelve months ending a quarter before and $ -36.32 millions from the TTM period ending Mar 31 2020.

Chiasma Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Chiasma Inc ' has realized cumulative trailing twelve months net loss of $ -90 millions in the Mar 31 2021 period.
The results are detiriorating as the cumulative net loss is becoming larger from $ -74.78 millions for the period from Dec 31 2020 to Mar 31 2020 and $ -36.32 millions for the twelve months ending in the quarter Mar 31 2020.

Chiasma Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
CHMA's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for CHMA's Competitors
Net Income Growth for Chiasma Inc 's Suppliers
Net Income Growth for CHMA's Customers

You may also want to know
CHMA's Annual Growth Rates CHMA's Profitability Ratios CHMA's Asset Turnover Ratio CHMA's Dividend Growth
CHMA's Roe CHMA's Valuation Ratios CHMA's Financial Strength Ratios CHMA's Dividend Payout Ratio
CHMA's Roa CHMA's Inventory Turnover Ratio CHMA's Growth Rates CHMA's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Net Income for the quarter ending Mar 31 2021
Lantheus Holdings Inc 169.94%$ 169.943 millions
Iqvia Holdings Inc 138.46%$ 138.462 millions
Hca Healthcare Inc 126.36%$ 126.361 millions
Fonar Corporation124.61%$ 124.608 millions
West Pharmaceutical Services Inc 103.50%$ 103.499 millions
Dexcom Inc 102.51%$ 102.513 millions
Lemaitre Vascular Inc 86.80%$ 86.799 millions
Rigel Pharmaceuticals Inc85.94%$ 85.944 millions
Hill rom Holdings Inc 85.71%$ 85.714 millions
Idexx Laboratories Inc82.64%$ 82.636 millions
Semler Scientific Inc 82.45%$ 82.454 millions
Abiomed Inc 78.80%$ 78.804 millions
Regeneron Pharmaceuticals Inc 78.55%$ 78.546 millions
Globus Medical Inc 74.68%$ 74.685 millions
Conmed Corporation66.36%$ 66.357 millions
Pro dex Inc 64.47%$ 64.468 millions
Becton Dickinson And Company63.93%$ 63.934 millions
Jrsis Health Care Corporation 57.48%$ 57.477 millions
Amedisys Inc 56.94%$ 56.937 millions
Mettler toledo International Inc 52.54%$ 52.538 millions
Magellan Health inc 52.48%$ 52.477 millions
Lhc Group Inc 49.71%$ 49.707 millions
Medpace Holdings Inc 49.57%$ 49.568 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com